江苏天瑞仪器股份有限公司 证券代码：300165 证券简称：天瑞仪器 公告编号：2024-058 关于立案调查事项进展暨风险提示的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 若后续经中国证监会行政处罚认定的事实，触及《深圳证券交易所创业板股 票上市规则》规定的重大违法强制退市情形，公司股票将被实施重大违法强制退 市。敬请投资者注意投资风险。 公司指定的信息披露媒体为《中国证券报》《上海证券报》《证券时报》以 及巨潮资讯网（www.cninfo.com.cn），有关公司的信息均以上述指定媒体刊登 的信息为准。 特此公告。 公司于 2024 年 4 月 25 日收到中国证监会《立案告知书》（证监立案字 0382024015 号），因公司涉嫌信息披露违法违规，根据《中华人民共和国证券 法》《中华人民共和国行政处罚法》等法律法规，中国证监会决定对公司立案。 公司已于 2024 年 4 月 26 日在指定信息披露媒体上披露了《关于收到中国证券监 督管理委员会立案告知书的公告》（公告编号：2024-022）。 截至目前，公司经营情况正常。中国证监会的调查尚在进行 ...

证券代码：300165 证券简称：天瑞仪器 公告编号：2024-051 江苏天瑞仪器股份有限公司 第六届董事会第十一次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 江苏天瑞仪器股份有限公司（以下简称"公司"）于 2024 年 8 月 12 日以电 子邮件方式向全体董事发出召开第六届董事会第十一次会议的通知。会议于 2024 年 8 月 23 日下午 2:00 在公司八楼会议室以现场表决和通讯表决相结合的 方式召开。会议应出席董事 9 人，实际出席董事 9 人（其中：独立董事莫卫民先 生、董事凌开舟先生、董事廖国荣先生以通讯表决方式出席本次会议）。公司监 事及高级管理人员列席了会议。本次会议的召集、召开程序符合《中华人民共和 国公司法》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司 规范运作》《公司章程》等有关规定。会议由董事长刘召贵先生主持。 二、董事会会议审议情况 经与会董事认真审议，形成如下决议： 1、审议通过了《2024 年半年度报告及其摘要》 有关公司《2024年半年度报告》及《2024年半年度 ...

证券代码：300165 证券简称：天瑞仪器 公告编号：2024-056 江苏天瑞仪器股份有限公司 关于会计政策变更的公告 财政部发布的第 17 号解释对"关于流动负债与非流动负债的划分""关于供 应商融资安排的披露""关于售后租回交易的会计处理"等内容进行了规定。 （二）本次变更前后采用的会计政策 1、本次会计政策变更前采用的会计政策 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示: 本次会计政策变更是江苏天瑞仪器股份有限公司（以下简称"公司"）根据 财政部发布的《企业会计准则解释第 17 号》（财会〔2023〕21 号）（以下简称"第 17 号解释"）的相关规定和要求进行的合理变更，不涉及对公司以前年度的追溯 调整，对公司财务状况、经营成果和现金流量无重大影响，不存在损害公司及全 体股东利益的情形。 一、本次会计政策变更概述 财政部于 2023 年 10 月 25 日发布第 17 号解释，自 2024 年 1 月 1 日起施行， 公司据此对执行的原相关会计政策进行相应变更。 本次会计政策变更系公司根据财政部发布的第 17 号解释相关规定和要求进 ...

[Important Notice, Table of Contents, and Definitions](index=1&type=section&id=%E7%AC%AC%E4%B8%80%E8%8A%82%20%E9%87%8D%E8%A6%81%E6%8F%90%E7%A4%BA%E3%80%81%E7%9B%AE%E5%BD%95%E5%92%8C%E9%87%8A%E4%B9%89) [Important Notice](index=1&type=section&id=%E9%87%8D%E8%A6%81%E6%8F%90%E7%A4%BA) The Board of Directors, Supervisory Board, and senior management guarantee the report's truthfulness, accuracy, and completeness; forward-looking statements are not substantive commitments; the company faces risks including PPP project collection, investigation, and goodwill impairment, with no plans for cash dividends, bonus shares, or capital increase from reserves - The company faces major risks including PPP project collection risk, the risk of being investigated by the CSRC for alleged information disclosure violations, and goodwill impairment risk[1](index=1&type=chunk) - The company's 2024 semi-annual profit distribution plan is to not distribute cash dividends, bonus shares, or convert capital reserves into share capital[1](index=1&type=chunk) [Definitions](index=5&type=section&id=%E9%87%8A%E4%B9%89) This section defines key terms used in the report, including abbreviations for the company, its subsidiaries, holding and participating companies, as well as specific references to regulatory bodies, accounting firms, and the reporting period - The reporting period is defined as **January 1 to June 30, 2024**[5](index=5&type=chunk) [Company Profile and Key Financial Indicators](index=7&type=section&id=%E7%AC%AC%E4%BA%8C%E8%8A%82%20%E5%85%AC%E5%8F%B8%E7%AE%80%E4%BB%8B%E5%92%8C%E4%B8%BB%E8%A6%81%E8%B4%A2%E5%8A%A1%E6%8C%87%E6%A0%87) [Company Profile](index=7&type=section&id=%E4%B8%80%E3%80%81%E5%85%AC%E5%8F%B8%E7%AE%80%E4%BB%8B) Jiangsu Skyray Instrument Co., Ltd (stock code: 300165) is a company listed on the Shenzhen Stock Exchange, with Liu Zhaogui as its legal representative Company Profile | Item | Content | | :--- | :--- | | **Stock Abbreviation** | Skyray Instrument | | **Stock Code** | 300165 | | **Listed Exchange** | Shenzhen Stock Exchange | | **Company Name** | Jiangsu Skyray Instrument Co., Ltd | | **Legal Representative** | Liu Zhaogui | [Key Accounting Data and Financial Indicators](index=8&type=section&id=%E5%9B%9B%E3%80%81%E4%B8%BB%E8%A6%81%E4%BC%9A%E8%AE%A1%E6%95%B0%E6%8D%AE%E5%92%8C%E8%B4%A2%E5%8A%A1%E6%8C%87%E6%A0%87) During the reporting period, the company's performance significantly declined, with operating revenue decreasing by **12.89%** year-on-year and net profit attributable to shareholders turning from profit to loss, down **163.30%**; however, net cash flow from operating activities fundamentally improved, increasing by **110.02%** year-on-year, primarily due to reduced payments for PPP projects Key Accounting Data and Financial Indicators | Indicator | Current Period | Prior Year Period | YoY Change | | :--- | :--- | :--- | :--- | | **Operating Revenue (yuan)** | 379,766,029.27 | 435,936,458.75 | -12.89% | | **Net Profit Attributable to Listed Company Shareholders (yuan)** | -14,889,218.28 | 23,521,817.36 | -163.30% | | **Net Profit Attributable to Listed Company Shareholders Excluding Non-Recurring Gains and Losses (yuan)** | -15,705,163.36 | 22,501,662.59 | -169.80% | | **Net Cash Flow from Operating Activities (yuan)** | 21,046,900.82 | -209,945,215.92 | 110.02% | | **Basic Earnings Per Share (yuan/share)** | -0.0300 | 0.0475 | -163.16% | | **Weighted Average Return on Net Assets** | -1.08% | 1.54% | -2.62% | [Non-Recurring Gains and Losses Items and Amounts](index=8&type=section&id=%E5%85%AD%E3%80%81%E9%9D%9E%E7%BB%8F%E5%B8%B8%E6%80%A7%E6%8D%9F%E7%9B%8A%E9%A1%B9%E7%9B%AE%E5%8F%8A%E9%87%91%E9%A2%9D) During the reporting period, the company's non-recurring gains and losses totaled **816,000 yuan**, primarily comprising government grants of **1.196 million yuan**, non-current asset disposal gains of **376,000 yuan**, and net other non-operating expenses of **-349,000 yuan** Non-Recurring Gains and Losses Items and Amounts | Item | Amount (yuan) | | :--- | :--- | | Non-current asset disposal gains and losses | 375,983.43 | | Government grants recognized in current profit/loss | 1,195,578.73 | | Other non-operating income and expenses | -536,216.54 | | **Total** | **815,945.08** | [Management Discussion and Analysis](index=10&type=section&id=%E7%AC%AC%E4%B8%89%E8%8A%82%20%E7%AE%A1%E7%90%86%E5%B1%82%E8%AE%A8%E8%AE%BA%E4%B8%8E%E5%88%86%E6%9E%90) [Overview of Main Business Activities During the Reporting Period](index=10&type=section&id=%E4%B8%80%E3%80%81%E6%8A%A5%E5%91%8A%E6%9C%9F%E5%86%85%E5%85%AC%E5%8F%B8%E4%BB%8E%E4%BA%8B%E7%9A%84%E4%B8%BB%E8%A6%81%E4%B8%9A%E5%8A%A1) The company's main business covers four segments: analytical and testing instruments, environmental governance, in-vitro diagnostics, and third-party testing services, with analytical and testing instruments as its core, focusing on spectrometers, chromatographs, and mass spectrometers, transitioning from a single instrument supplier to a comprehensive analytical and testing service provider - The company's main business is divided into four segments: analytical and testing instruments, environmental governance, in-vitro diagnostics (IVD), and third-party testing services[16](index=16&type=chunk) - Analytical and testing instruments are the company's core products, with technology centered on spectrometers, chromatographs, and mass spectrometers, widely applied across industries such as electronics, chemicals, food safety, and environmental protection[17](index=17&type=chunk) - The company's performance is driven by external factors such as industrial policy support (e.g., equipment upgrades), downstream industry development, and accelerated domestic substitution[26](index=26&type=chunk) [Analysis of Core Competitiveness](index=12&type=section&id=%E4%BA%8C%E3%80%81%E6%A0%B8%E5%BF%83%E7%AB%9E%E4%BA%89%E5%8A%9B%E5%88%86%E6%9E%90) During the reporting period, the company strengthened R&D innovation, securing **20** new authorized patents (**8** invention patents), filing **19** new patent applications (**4** invention patents), and obtaining **5** new computer software copyright registration certificates, solidifying its technological leadership - During the reporting period, the company and its subsidiaries obtained **20** new authorized patents (**8** invention patents), filed **19** new patent applications (**4** invention patents), and added **5** new software copyrights[28](index=28&type=chunk) [Analysis of Main Business Operations](index=12&type=section&id=%E4%B8%89%E3%80%81%E4%B8%BB%E8%A6%81%E4%B8%9A%E5%8A%A1%E5%88%86%E6%9E%90) During the reporting period, the company's operating revenue decreased by **12.89%** year-on-year due to fewer orders; experimental analytical instruments revenue fell by **8.89%**, environmental engineering and services revenue sharply declined by **35.37%**, while only third-party testing business grew by **13.72%**, with operating cash flow significantly improving due to reduced payments for PPP project goods and services Key Financial Data Year-on-Year Changes | Item | Current Period | Prior Year Period | YoY Change | Reason for Change | | :--- | :--- | :--- | :--- | :--- | | **Operating Revenue** | 379,766,029.27 | 435,936,458.75 | -12.89% | Decreased Orders | | **Operating Cost** | 226,034,176.73 | 265,224,313.13 | -14.78% | Decreased Revenue Leading to Decreased Costs | | **Net Cash Flow from Operating Activities** | 21,046,900.82 | -209,945,215.92 | 110.02% | Reduced Payments for PPP Project Goods and Services | Revenue by Product or Service (yuan) | Product or Service | Operating Revenue (yuan) | Operating Cost (yuan) | Gross Margin | Operating Revenue YoY Change | | :--- | :--- | :--- | :--- | :--- | | **Experimental Analytical Instruments and Systems** | 179,969,872.53 | 73,126,875.38 | 59.37% | -8.89% | | **Environmental Engineering and Services** | 85,327,447.52 | 83,389,515.63 | 2.27% | -35.37% | | **Third-Party Testing** | 39,768,730.22 | 26,683,326.28 | 32.90% | 13.72% | [Analysis of Non-Core Business Operations](index=14&type=section&id=%E5%9B%9B%E3%80%81%E9%9D%9E%E4%B8%BB%E8%90%A5%E4%B8%9A%E5%8A%A1%E5%88%86%E6%9E%90) During the reporting period, non-core operations significantly impacted profit, with asset impairment losses reaching **-5.836 million yuan**, accounting for **66.80%** of total profit, primarily due to inventory write-downs and contract asset impairment; other items like investment income and non-operating income/expenses also negatively affected total profit and are not sustainable Non-Core Business Analysis | Item | Amount (yuan) | Share of Total Profit | Reason for Formation | | :--- | :--- | :--- | :--- | | **Investment Income** | 553,749.02 | -6.34% | Primarily due to increased investment income from associates and joint ventures | | **Asset Impairment** | -5,836,141.73 | 66.80% | Primarily due to inventory write-downs and contract asset impairment | | **Non-Operating Income** | 187,257.07 | -2.14% | Primarily due to non-payable amounts | | **Non-Operating Expenses** | -704,757.58 | -8.07% | Primarily due to compensation payments | | **Asset Disposal Gains** | 375,983.43 | -4.30% | Primarily due to gains from disposal of fixed assets | [Analysis of Assets and Liabilities](index=14&type=section&id=%E4%BA%94%E3%80%81%E8%B5%84%E4%BA%A7%E5%8F%8A%E8%B4%9F%E5%80%BA%E7%8A%B6%E5%86%B5%E5%88%86%E6%9E%90) At the end of the reporting period, the company's total assets were **3.694 billion yuan**, a **1.66%** decrease from the beginning of the year; contract assets constituted the largest portion at **55.20%**, increasing due to recognized construction revenue and warranty deposits from PPP projects; long-term borrowings, accounting for **30.84%**, rose due to increased loans for ongoing PPP projects, while cash and cash equivalents decreased by **23.96%** primarily for bank loan repayments - Cash and cash equivalents at period-end decreased by **23.96%** from the beginning of the year, primarily due to repayment of some bank loans[34](index=34&type=chunk) - Contract assets at period-end increased by **2.01%** from the beginning of the year, primarily due to commercial operation of some PPP project sites, leading to recognized construction revenue and increased warranty deposits[35](index=35&type=chunk) - Inventory balance decreased by **12.07%** from the beginning of the year, primarily due to the completion and cost transfer of some projects[35](index=35&type=chunk) - Long-term borrowings increased by **1.11%** from the beginning of the year, primarily due to increased loans for ongoing PPP projects[35](index=35&type=chunk) [Analysis of Investment Status](index=17&type=section&id=%E5%85%AD%E3%80%81%E6%8A%95%E8%B5%84%E7%8A%B6%E5%86%B5%E5%88%86%E6%9E%90) During the reporting period, the company made no new significant equity or non-equity investments; **15.4727 million yuan** of raised funds were invested during the period, with cumulative investments reaching **1.3053 billion yuan**; over-raised funds were primarily used for acquiring Skyray Environment, Baisi Bio, Guoce Testing, Panhe Keyi, and supplementing working capital; the company also used **35 million yuan** of over-raised funds to purchase wealth management products, which have since been fully redeemed - Investment during the reporting period was **0 yuan**, a **100%** year-on-year decrease[39](index=39&type=chunk) - Total raised funds amounted to **1.107 billion yuan**, with **15.4727 million yuan** invested during the reporting period, and cumulative investments reaching **1.3053 billion yuan**[40](index=40&type=chunk) - Over-raised funds were primarily used for acquiring Suzhou Skyray Environment, Shanghai Baisi Bio, Jiangsu Guoce Testing, Shanghai Panhe Keyi, and supplementing working capital[41](index=41&type=chunk)[43](index=43&type=chunk) - During the reporting period, **35 million yuan** of raised funds were used to purchase bank wealth management products, which have since been fully redeemed[49](index=49&type=chunk) [Analysis of Major Holding and Participating Companies](index=22&type=section&id=%E5%85%AB%E3%80%81%E4%B8%BB%E8%A6%81%E6%8E%A7%E8%82%A1%E5%8F%82%E8%82%A1%E5%85%AC%E5%8F%B8%E5%88%86%E6%9E%90) During the reporting period, several major subsidiaries incurred losses: Skyray Environment lost **18.28 million yuan**, Xiantao Skyray lost **18.78 million yuan**, Panhe Keyi lost **7.01 million yuan**, and Baisi Bio lost **3.82 million yuan**; in contrast, Guoce Testing achieved a profit of **440,000 yuan**, and PPP project companies like Ya'an Skyray and Anyue Skyray also reported profits Major Subsidiary Operating Performance (yuan) | Company Name | Type | Operating Revenue (yuan) | Operating Profit (yuan) | Net Profit (yuan) | | :--- | :--- | :--- | :--- | :--- | | **Skyray Environment** | Subsidiary | 41,514,178.20 | -18,345,793.11 | -18,281,978.06 | | **Baisi Bio** | Subsidiary | 7,352,994.07 | -3,817,927.34 | -3,817,927.34 | | **Guoce Testing** | Subsidiary | 39,768,730.22 | 424,569.99 | 444,751.60 | | **Xiantao Skyray** | Subsidiary | 80,893,287.26 | -18,753,185.30 | -18,776,107.25 | | **Panhe Keyi** | Subsidiary | 30,088,214.29 | -6,939,947.37 | -7,011,342.27 | | **Ya'an Skyray** | Subsidiary | 17,702,542.65 | 8,293,792.34 | 7,256,980.80 | | **Anyue Skyray** | Subsidiary | 14,983,508.66 | 6,611,595.14 | 6,357,790.10 | [Risks Faced by the Company and Countermeasures](index=27&type=section&id=%E5%8D%81%E3%80%81%E5%85%AC%E5%8F%B8%E9%9D%A2%E4%B8%B4%E7%9A%84%E9%A3%8E%E9%99%A9%E5%92%8C%E5%BA%94%E5%AF%B9%E6%8E%AA%E6%96%BD) The company identified three core risks: delayed PPP project collections potentially impacting current profit; an ongoing CSRC investigation into alleged information disclosure violations, posing a risk of mandatory delisting for major infractions; and goodwill impairment risk from acquisitions, which could reduce current profit; the company plans to mitigate these by strengthening accounts receivable management, cooperating with investigations, improving information disclosure, and optimizing resource integration - The company faces PPP project collection risk, where some project payments may be delayed, negatively impacting current profit[59](index=59&type=chunk) - The company was placed under investigation by the China Securities Regulatory Commission on **April 25, 2024**, for alleged information disclosure violations; if deemed a major violation, it may face mandatory delisting risk[60](index=60&type=chunk) - The company has significant goodwill from mergers and acquisitions; if the acquired entities' future operating conditions deteriorate, there is a risk of goodwill impairment, which would negatively impact profit[61](index=61&type=chunk) [Corporate Governance](index=29&type=section&id=%E7%AC%AC%E5%9B%9B%E8%8A%82%20%E5%85%AC%E5%8F%B8%E6%B2%BB%E7%90%86) [Information on Annual and Extraordinary Shareholder Meetings Held During the Reporting Period](index=29&type=section&id=%E4%B8%80%E3%80%81%E6%8A%A5%E5%91%8A%E6%9C%9F%E5%86%85%E5%8F%AC%E5%BC%80%E7%9A%84%E5%B9%B4%E5%BA%A6%E8%82%A1%E4%B8%9C%E5%A4%A7%E4%BC%9A%E5%92%8C%E4%B8%B4%E6%97%B6%E8%82%A1%E4%B8%9C%E5%A4%A7%E4%BC%9A%E7%9A%84%E6%9C%89%E5%85%B3%E6%83%85%E5%86%B5) During the reporting period, the company held two shareholder meetings: the 2023 Annual General Meeting and the 2024 First Extraordinary General Meeting, with investor participation rates of **24.82%** and **19.78%** respectively Shareholder Meeting Convening Status | Meeting Session | Meeting Type | Investor Participation Rate | Meeting Date | | :--- | :--- | :--- | :--- | | 2023 Annual General Meeting | Annual General Meeting | 24.82% | 2024年05月17日 | | 2024 First Extraordinary General Meeting | Extraordinary General Meeting | 19.78% | 2024年06月28日 | [Changes in Directors, Supervisors, and Senior Management](index=29&type=section&id=%E4%BA%8C%E3%80%81%E5%85%AC%E5%8F%B8%E8%91%A3%E4%BA%8B%E3%80%81%E7%9B%91%E4%BA%8B%E3%80%81%E9%AB%98%E7%BA%A7%E7%AE%A1%E7%90%86%E4%BA%BA%E5%91%98%E5%8F%98%E5%8A%A8%E6%83%85%E5%86%B5) During the reporting period, the company's Board of Directors saw changes, with Yang Bohong and Li Gang resigning as directors due to personal reasons, and Liao Guorong and Zhang Xiumei elected as new directors - Directors Yang Bohong and Li Gang resigned due to personal reasons[65](index=65&type=chunk) - Liao Guorong and Zhang Xiumei were elected as new directors on **June 28, 2024**[65](index=65&type=chunk) [Environmental and Social Responsibility](index=30&type=section&id=%E7%AC%AC%E4%BA%94%E8%8A%82%20%E7%8E%AF%E5%A2%83%E5%92%8C%E7%A4%BE%E4%BC%9A%E8%B4%A3%E4%BB%BB) [Significant Environmental Issues](index=30&type=section&id=%E4%B8%80%E3%80%81%E9%87%8D%E5%A4%A7%E7%8E%AF%E4%BF%9D%E9%97%AE%E9%A2%98%E6%83%85%E5%86%B5) The company's subsidiary, Ya'an Skyray, is designated as a key polluting unit, primarily for water pollutants; during the reporting period, Ya'an Skyray strictly adhered to environmental regulations, with all pollutant emissions within limits, and has developed an emergency response plan for environmental incidents, incurring no administrative penalties for environmental issues - The company's subsidiary, Ya'an Skyray, is designated as a key polluting unit by environmental protection authorities, with primary pollutants being water pollutants (ammonia nitrogen, total phosphorus, total nitrogen, CODCr)[67](index=67&type=chunk)[68](index=68&type=chunk) - During the reporting period, Ya'an Skyray's total pollutant emissions were within the approved limits, with no instances of exceeding standards[68](index=68&type=chunk) - The company has formulated and filed an 'Emergency Response Plan for Environmental Incidents' and received no administrative penalties for environmental issues during the reporting period[71](index=71&type=chunk) [Social Responsibility](index=31&type=section&id=%E4%BA%8C%E3%80%81%E7%A4%BE%E4%BC%9A%E8%B4%A3%E4%BB%BB%E6%83%85%E5%86%B5) The company actively fulfills its social responsibilities by communicating with investors through various channels to protect shareholder rights, prioritizing human capital by focusing on employee development and welfare to foster mutual growth, and operating legally while actively paying taxes to support local economic development - The company maintains communication with investors through platforms like investor hotlines and 'Hudongyi' to protect shareholder rights[72](index=72&type=chunk) - The company prioritizes employee career development, labor protection, and well-being, establishing a comprehensive performance appraisal and welfare system[72](index=72&type=chunk) [Significant Matters](index=33&type=section&id=%E7%AC%AC%E5%85%AD%E8%8A%82%20%E9%87%8D%E8%A6%81%E4%BA%8B%E9%A1%B9) [Litigation Matters](index=34&type=section&id=%E5%85%AB%E3%80%81%E8%AF%89%E8%AE%BC%E4%BA%8B%E9%A1%B9) During the reporting period, the company had no significant litigation or arbitration matters; among other lawsuits, newly won cases totaled **4.6568 million yuan**, and newly lost cases totaled **2.0245 million yuan**; as of the end of the reporting period, the cumulative amount involved in pending lawsuits for the company and its subsidiaries was **60.189 million yuan** Litigation Status | Litigation Status | Amount Involved (ten thousand yuan) | Status | | :--- | :--- | :--- | | Newly Won Cases (Executed) | 17.14 | Closed | | Newly Won Cases (Pending Execution) | 448.54 | Closed | | Newly Lost Cases (Executed) | 202.45 | Closed | | Cumulative Pending Judgment Cases | 6,018.9 | Pending Judgment | [Penalties and Rectification Status](index=34&type=section&id=%E4%B9%9D%E3%80%81%E7%BD%9A%E5%A4%84%E5%8F%8A%E6%95%B4%E6%94%B9%E6%83%85%E5%86%B5) During the reporting period, the company and related parties received multiple penalties: controlling subsidiary Anyue Skyray was fined for failing to implement safety production responsibilities; the company is under CSRC investigation for alleged information disclosure violations and received a warning letter from Jiangsu CSRC for prior financial misstatements; additionally, the company received a Shenzhen Stock Exchange regulatory letter for providing unauthorized financial assistance for employee housing/car purchases; the company has formulated and implemented rectification measures for all issues - Controlling subsidiary Anyue Skyray Water Co., Ltd. was fined **301,000 yuan** for failing to implement its primary responsibility for production safety[78](index=78&type=chunk)[79](index=79&type=chunk)[80](index=80&type=chunk) - The company was placed under investigation by the China Securities Regulatory Commission on **April 26, 2024**, for alleged information disclosure violations[80](index=80&type=chunk) - The company, Chairman Liu Zhaogui, General Manager Ying Gang, and then-CFO Wu Zhaobing received a warning letter from Jiangsu CSRC for misstating certain periodic reports in 2021-2022 due to non-compliance with accounting standards for construction service revenue recognition and measurement[80](index=80&type=chunk)[81](index=81&type=chunk) - The company received a Shenzhen Stock Exchange regulatory letter for providing unauthorized loans to employees for housing and car purchases (constituting financial assistance) without timely fulfilling review procedures and disclosure obligations[99](index=99&type=chunk)[100](index=100&type=chunk) [Explanation of Other Significant Matters](index=42&type=section&id=%E5%8D%81%E4%B8%89%E3%80%81%E5%85%B6%E4%BB%96%E9%87%8D%E5%A4%A7%E4%BA%8B%E9%A1%B9%E7%9A%84%E8%AF%B4%E6%98%8E) On **May 22, 2024**, the company decided to terminate its 2023 private placement of A-shares; the report also reiterated the significant events of receiving a CSRC investigation notice and a Jiangsu CSRC warning letter on **April 25, 2024**, and highlighted related risks - The company's Board of Directors convened on **May 22, 2024**, deciding to terminate the 2023 private placement of A-shares[97](index=97&type=chunk) - The report reiterated the company's ongoing CSRC investigation for alleged information disclosure violations and the warning letter from Jiangsu CSRC regarding prior financial misstatements[98](index=98&type=chunk) [Share Changes and Shareholder Information](index=44&type=section&id=%E7%AC%AC%E4%B8%83%E8%8A%82%20%E8%82%A1%E4%BB%BD%E5%8F%98%E5%8A%A8%E5%8F%8A%E8%82%A1%E4%B8%9C%E6%83%85%E5%86%B5) [Share Change Status](index=44&type=section&id=%E4%B8%80%E3%80%81%E8%82%A1%E4%BB%BD%E5%8F%98%E5%8A%A8%E6%83%85%E5%86%B5) During the reporting period, the company's total share capital of **495,511,725 shares** remained unchanged; restricted shares decreased by **3,425 shares** due to the unlocking of executive-held shares upon departure, with a corresponding increase in unrestricted shares by **3,425 shares** Share Change Status | Share Class | Quantity Before Change | Current Change | Quantity After Change | | :--- | :--- | :--- | :--- | | **Restricted Shares** | 74,983,040 | -3,425 | 74,979,615 | | **Unrestricted Shares** | 420,528,685 | +3,425 | 420,532,110 | | **Total Share Capital** | 495,511,725 | 0 | 495,511,725 | [Shareholder Numbers and Shareholding Status](index=46&type=section&id=%E4%B8%89%E3%80%81%E5%85%AC%E5%8F%B8%E8%82%A1%E4%B8%9C%E6%95%B0%E9%87%8F%E5%8F%8A%E6%8C%81%E8%82%A1%E6%83%85%E5%86%B5) As of the end of the reporting period, the company had **25,892** common shareholders; controlling shareholder and de facto controller Liu Zhaogui held a **16.13%** stake; among the top ten shareholders, Mr. Liu Zhaogui and Shanghai Muxin Private Equity Fund Management Co., Ltd. - Muxin Tianzehui No. 4 Private Securities Investment Fund are parties acting in concert - At the end of the reporting period, the total number of common shareholders was **25,892**[105](index=105&type=chunk) Top Five Shareholders' Shareholding Status | Shareholder Name | Shareholding Percentage | Number of Shares Held | Number of Restricted Shares Held | | :--- | :--- | :--- | :--- | | Liu Zhaogui | 16.13% | 79,914,203 | 59,935,652 | | Guangzhou Lidu Virtual Reality Technology Partnership (Limited Partnership) | 5.01% | 24,825,137 | 0 | | Shanghai Muxin Private Equity Fund Management Co., Ltd. - Muxin Tianzehui No. 4 | 4.24% | 21,000,000 | 0 | | Ying Gang | 3.56% | 17,642,917 | 13,232,188 | | Suzhou Zhengyuan Xinyi Asset Management Co., Ltd. - Zhengyuan Xingye No. 2 | 1.57% | 7,788,966 | 0 | - Shareholder Liu Zhaogui and Shanghai Muxin Private Equity Fund Management Co., Ltd. - Muxin Tianzehui No. 4 Private Securities Investment Fund are parties acting in concert[106](index=106&type=chunk) [Financial Report](index=51&type=section&id=%E7%AC%AC%E5%8D%81%E8%8A%82%20%E8%B4%A2%E5%8A%A1%E6%8A%A5%E5%91%8A) [Audit Report](index=51&type=section&id=%E4%B8%80%E3%80%81%E5%AE%A1%E8%AE%A1%E6%8A%A5%E5%91%8A) The company's 2024 semi-annual financial report is unaudited - The company's semi-annual financial report is unaudited[116](index=116&type=chunk) [Financial Statements](index=51&type=section&id=%E4%BA%8C%E3%80%81%E8%B4%A2%E5%8A%A1%E6%8A%A5%E8%A1%A8) Financial statements show that as of the end of the reporting period, the company's total assets were **3.694 billion yuan**, total liabilities **2.273 billion yuan**, and equity attributable to the parent company **1.371 billion yuan**; operating revenue for the period was **380 million yuan**, net profit attributable to the parent company was **-14.89 million yuan**, and net cash flow from operating activities was **21.05 million yuan** [Consolidated Balance Sheet](index=51&type=section&id=%E5%90%88%E5%B9%B6%E8%B5%84%E4%BA%A7%E8%B4%9F%E5%80%BA%E8%A1%A8) As of **June 30, 2024**, the company's total assets were **3.694 billion yuan**, a **1.66%** decrease from the beginning of the period; total liabilities were **2.273 billion yuan**, down **2.14%**; equity attributable to the parent company was **1.371 billion yuan**, a **1.01%** decrease; the asset-liability ratio was **61.54%** Consolidated Balance Sheet Key Items (yuan) | Item | Period-End Balance (yuan) | Period-Start Balance (yuan) | | :--- | :--- | :--- | | **Total Assets** | 3,694,059,210.86 | 3,756,441,828.51 | | **Total Liabilities** | 2,273,277,670.84 | 2,322,947,416.40 | | **Total Equity Attributable to Parent Company Owners** | 1,370,707,755.64 | 1,384,727,884.10 | | **Total Owners' Equity** | 1,420,781,540.02 | 1,433,494,412.11 | [Consolidated Income Statement](index=55&type=section&id=%E5%90%88%E5%B9%B6%E5%88%A9%E6%B6%A6%E8%A1%A8) In the first half of **2024**, the company achieved total operating revenue of **380 million yuan**, a **12.89%** year-on-year decrease; total operating costs were **369 million yuan**; influenced by declining revenue and credit impairment losses, operating profit was **-8.22 million yuan**, total profit was **-8.74 million yuan**, and net profit attributable to parent company shareholders was **-14.89 million yuan**, turning from profit to loss year-on-year Consolidated Income Statement Key Items (yuan) | Item | H1 2024 (yuan) | H1 2023 (yuan) | | :--- | :--- | :--- | | **I. Total Operating Revenue** | 379,766,029.27 | 435,936,458.75 | | **II. Total Operating Costs** | 369,421,713.57 | 427,206,021.78 | | **III. Operating Profit** | -8,219,384.64 | 28,917,146.60 | | **IV. Total Profit** | -8,736,885.15 | 28,885,765.65 | | **V. Net Profit** | -13,581,961.91 | 22,927,993.18 | | **Net Profit Attributable to Parent Company Shareholders** | -14,889,218.28 | 23,521,817.36 | [Consolidated Cash Flow Statement](index=59&type=section&id=%E5%90%88%E5%B9%B6%E7%8E%B0%E9%87%91%E6%B5%81%E9%87%8F%E8%A1%A8) In the first half of **2024**, net cash flow from operating activities was **21.05 million yuan**, a significant improvement from **-210 million yuan** in the prior year; net cash outflow from investing activities was **10.54 million yuan**, and from financing activities was **68.19 million yuan**; cash and cash equivalents at period-end totaled **182 million yuan** Consolidated Cash Flow Statement Key Items (yuan) | Item | H1 2024 (yuan) | H1 2023 (yuan) | | :--- | :--- | :--- | | **Net Cash Flow from Operating Activities** | 21,046,900.82 | -209,945,215.92 | | **Net Cash Flow from Investing Activities** | -10,542,340.88 | -29,395,478.82 | | **Net Cash Flow from Financing Activities** | -68,187,025.47 | 70,473,540.17 | | **Net Increase in Cash and Cash Equivalents** | -57,309,433.10 | -168,951,767.34 | | **Cash and Cash Equivalents at Period-End** | 181,860,046.10 | 240,980,139.51 | [Notes to Consolidated Financial Statements](index=89&type=section&id=%E4%B8%83%E3%80%81%E5%90%88%E5%B9%B6%E8%B4%A2%E5%8A%A1%E6%8A%A5%E8%A1%A8%E9%A1%B9%E7%9B%AE%E6%B3%A8%E9%87%8A) This section details the composition and changes of major accounts in the consolidated financial statements, highlighting significant balances in accounts receivable and contract assets primarily related to PPP projects, goodwill with an original value of **552 million yuan** and accumulated impairment provisions of **477 million yuan**, and substantial guarantees provided for bank loans of subsidiaries Ya'an Skyray and Anyue Skyray - As of period-end, the top five accounts receivable and contract asset balances by debtor totaled **2.324 billion yuan**, accounting for **87.01%** of the total, primarily related to PPP projects[224](index=224&type=chunk) - Goodwill had an original book value of **552 million yuan**, with an impairment provision balance of **477 million yuan** at period-end, showing no change; it primarily arose from acquisitions of Skyray Environment, Panhe Keyi, Baisi Bio, and other companies[283](index=283&type=chunk)[284](index=284&type=chunk) - The company provided total guarantees of **1.89 billion yuan** for bank loans of subsidiaries Ya'an Skyray and Anyue Skyray, primarily for PPP project construction[312](index=312&type=chunk)[313](index=313&type=chunk)

| | 资金占用方名称 | 占用方与上市公司 | 上市公司核算的会 | 2024 年期初往来资金 | 2024 年半年度往 来累计发生金额 | 2024 年半年 度往来资金的 | 2024 年半年度偿还 | 2024 | 年 6 月末往来资 | 占用形成原因 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 非经营性资金占用 | | 的关联关系 | 计科目 | 余额 | | | 累计发生金额 | | 金余额 | | | | | | | | | （不含利息） | 利息（如有） | | | | | | | 控股股东、实际控 制人及其附属企业 | - | - | - | - | - | - | - | | - | | 非经营性占用 | | 小计 | —— | —— | —— | - | - | - | - | | - | | —— | | 前控股股东、实际 | | | | | | | | | | | | | 控制人及其附属企 | - | - | - | - | - | - | - | | - | ...

证券代码：300165 证券简称：天瑞仪器 公告编号：2024-053 江苏天瑞仪器股份有限公司 关于计提资产减值准备的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 江苏天瑞仪器股份有限公司（以下简称"公司"）于2024年8月23日召开了 第六届董事会第十一次会议和第六届监事会第八次会议，审议通过了《关于计提 资产减值准备的议案》。现将有关事项公告如下： 一、本次计提资产减值准备情况概述 公司根据《深圳证券交易所上市公司自律监管指引第2号——创业板上市公 司规范运作》《企业会计准则》及公司会计政策等相关规定，为了更加真实、准 确的反映公司的资产与财务状况，基于谨慎性原则，对合并报表范围内截至2024 年6月30日的应收账款、应收票据、应收款项融资、预付款项、其他应收款和长 期应收款、存货、合同资产等资产进行了全面清查。对资产减值的可能性进行了 充分的评估和分析，判断存在可能发生减值的迹象，确定了需计提的资产减值准 备。 公 司 及 下 属 子 公 司 2024 年 上 半 年 计 提 的 各 项 资 产 减 值 准 备 合 计 29,529,530.0 ...

证券代码：300165 证券简称：天瑞仪器 公告编号：2024-052 江苏天瑞仪器股份有限公司 第六届监事会第八次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 江苏天瑞仪器股份有限公司（以下简称"公司"）于 2024 年 8 月 12 日以电 子邮件方式向全体监事发出召开第六届监事会第八次会议的通知，会议于 2024 年 8 月 23 日上午 10：00 在公司八楼会议室以现场会议的方式召开。会议应出席 监事3人，实际出席监事3人。董事会秘书肖廷良列席会议。会议由监事会主席 徐应根召集和主持，会议的召开符合有关法律、行政法规、部门规章、规范性 文件和《公司章程》的规定。 二、监事会会议审议情况 经全体监事认真审议，形成决议如下： 1、审议通过了《2024 年半年度报告及其摘要》 三、备查文件 有关公司《2024 年半年度报告》及《2024 年半年度报告摘要》详见中国证 监会指定创业板信息披露网站巨潮资讯网（www.cninfo.com.cn）;《2024 年半 年度报告及其摘要披露的提示性公告》刊登于 2024 年 8 ...

江苏天瑞仪器股份有限公司 2024 年半年度募集资金存放与使用情况的专项报告 一、募集资金基本情况 江苏天瑞仪器股份有限公司（以下简称"公司"）经中国证券监督管理委员 会"证监许可[2010]1901号"文核准，首次公开发行人民币普通股（A股）1,850 万股，发行价格为每股65元，募集资金总额为120,250.00万元，扣除承销及保荐 费、审计费、律师费、信息披露费等其他发行费用9,480.82万元后，实际募集资 金净额为110,769.18万元。以上募集资金已由江苏公证天业会计师事务所有限公 司于2011年1月19日对公司首次公开发行股票的资金到位情况进行了审验，并出 具"苏公W[2011]B008号"《验资报告》。 截至2024年06月30日，累计使用募集资金金额为130,530.13万元，募集资金 本年度实际使用金额为1,547.27万元，截至2024年06月30日，尚未使用的募集资 金余额为2,238.87万元。 二、募集资金存放和管理情况 （一）《募集资金管理制度》的制定和执行情况 为规范募集资金的管理和使用，提高募集资金使用的效率和效果，防范资金 使用风险，保护投资者利益。本公司严格按照中国证券 ...

证券代码：300165 证券简称：天瑞仪器 公告编号：2024-050 江苏天瑞仪器股份有限公司 关于立案调查事项进展暨风险提示的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示: 截至目前，公司经营情况正常。中国证监会的调查尚在进行中，公司尚未收 到就上述立案调查事项的结论性意见或决定。在立案调查期间，公司将积极配合 中国证监会的调查工作，并严格按照监管要求履行信息披露义务。 二、风险提示 若后续经中国证监会行政处罚认定的事实，触及《深圳证券交易所创业板股 票上市规则》规定的重大违法强制退市情形，公司股票将被实施重大违法强制退 市。敬请投资者注意投资风险。 公司指定的信息披露媒体为《中国证券报》《上海证券报》《证券时报》以 及巨潮资讯网（www.cninfo.com.cn），有关公司的信息均以上述指定媒体刊登 的信息为准。 特此公告。 江苏天瑞仪器股份有限公司董事会 二○二四年八月二十三日 江苏天瑞仪器股份有限公司（以下简称"公司"）因涉嫌信息披露违法违规, 目前正在被中国证券监督管理委员会（以下简称"中国证监会"）立案调查,若后 续经中国证监 ...

法定代表人：刘佳丽 住所：上海市浦东新区广丹路 222 弄 20 号 证券代码：300165 证券简称：天瑞仪器 公告编号：2024－049 江苏天瑞仪器股份有限公司 关于全资子公司法定代表人变更的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、误导性 陈述或重大遗漏。 江苏天瑞仪器股份有限公司于近日收到全资子公司上海贝西生物科技有限 公司（以下简称"贝西生物"）通知，贝西生物于近日完成了法定代表人工商变 更登记手续，取得了上海市浦东新区市场监督管理局换发的《营业执照》。其法 定代表人由"黄波"变更为"刘佳丽"。贝西生物变更后的新营业执照信息如下： 公司名称：上海贝西生物科技有限公司 经营范围：许可项目：第三类医疗器械经营；第二类医疗器械生产；第三类 医疗器械生产；货物进出口，技术进出口。（依法须经批准的项目，经相关部门 批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准） 一般项目：医疗器械、诊断试剂及相关设备的研发，并提供相关的技术开发、技 术咨询、技术服务、技术转让，化工产品（不含许可类化工产品）、仪器仪表、 汽车新车、软件、第一类医疗器械、第二类医疗器械 ...